You are currently viewing UCL: UCL spinout raises £117m to trial ‘pioneering’ cell therapy

UCL: UCL spinout raises £117m to trial ‘pioneering’ cell therapy

  • Post author:
  • Post category:Uncategorized

The oversubscribed Series B financing round was co-led by Jeito Capital, Ridgeback Capital Investments, SV Health Investors and Fidelity Management & Research Company LLC. Founding investor Syncona also participated in the financing round. Quell was formed in 2019 by leading academics from UCL, King’s College London and Hannover Medical School, including UCL Professors Hans Stauss […]